Parkman Healthcare Partners LLC - Q1 2022 holdings

$342 Million is the total value of Parkman Healthcare Partners LLC's 80 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 40.5% .

 Value Shares↓ Weighting
IRTC BuyIRHYTHM TECHNOLOGIES INC$16,374,000
+124.5%
103,981
+67.8%
4.79%
+197.8%
UTHR SellUNITED THERAPEUTICS CORP DEL$13,296,000
-31.8%
74,107
-17.8%
3.89%
-9.5%
UNH SellUNITEDHEALTH GROUP INC$12,916,000
-32.0%
25,327
-33.0%
3.78%
-9.8%
SGEN BuySEAGEN INC$12,402,000
-0.7%
86,096
+6.6%
3.63%
+31.7%
IMUX BuyIMMUNIC INC$12,309,000
+32.0%
1,089,251
+11.8%
3.60%
+75.1%
THC BuyTENET HEALTHCARE CORP$11,964,000
+266.1%
139,185
+248.0%
3.50%
+385.6%
IQV SellIQVIA HLDGS INC$11,581,000
-43.9%
50,090
-31.5%
3.39%
-25.5%
ACRS SellACLARIS THERAPEUTICS INC$11,518,000
-22.8%
668,098
-34.9%
3.37%
+2.5%
DHR SellDANAHER CORPORATION$10,845,000
-44.0%
36,972
-37.2%
3.17%
-25.7%
XENE SellXENON PHARMACEUTICALS INC$9,299,000
-17.4%
304,186
-15.6%
2.72%
+9.5%
RCM BuyR1 RCM INC$9,177,000
+19.9%
342,923
+14.2%
2.69%
+58.9%
ALNY SellALNYLAM PHARMACEUTICALS INC$8,819,000
-9.8%
54,008
-6.4%
2.58%
+19.5%
CTLT BuyCATALENT INC$8,767,000
+12.4%
79,049
+29.7%
2.57%
+49.0%
CVS SellCVS HEALTH CORP$8,665,000
-37.0%
85,618
-35.8%
2.54%
-16.4%
CDMO BuyAVID BIOSERVICES INC$8,300,000
-1.9%
407,458
+40.5%
2.43%
+30.1%
COO SellCOOPER COS INC$8,179,000
-17.7%
19,585
-17.4%
2.39%
+9.2%
BCRX BuyBIOCRYST PHARMACEUTICALS INC$7,756,000
+40.0%
476,978
+19.2%
2.27%
+85.8%
ABBV SellABBVIE INC$7,413,000
+5.9%
45,731
-11.6%
2.17%
+40.4%
DXCM SellDEXCOM INC$6,516,000
-63.1%
12,737
-61.3%
1.91%
-51.1%
NBIX NewNEUROCRINE BIOSCIENCES INC$5,928,00063,234
+100.0%
1.74%
CDXS SellCODEXIS INC$5,529,000
-48.0%
268,144
-21.2%
1.62%
-31.1%
AVTR SellAVANTOR INC$5,356,000
-68.8%
158,365
-61.1%
1.57%
-58.7%
NTRA BuyNATERA INC$5,286,000
-54.6%
129,944
+4.3%
1.55%
-39.7%
RCUS BuyARCUS BIOSCIENCES INC$5,281,000
+11.4%
167,321
+42.9%
1.55%
+47.8%
ATEC BuyALPHATEC HLDGS INC$5,196,000
+93.5%
451,794
+92.3%
1.52%
+156.9%
IDXX SellIDEXX LABS INC$5,136,000
-28.9%
9,388
-14.4%
1.50%
-5.7%
APEN SellAPOLLO ENDOSURGERY INC$4,903,000
-36.7%
810,411
-11.8%
1.44%
-16.0%
SRRA NewSIERRA ONCOLOGY INC$4,869,000151,915
+100.0%
1.42%
TFX NewTELEFLEX INCORPORATED$4,435,00012,500
+100.0%
1.30%
LEGN NewLEGEND BIOTECH CORPsponsored ads$4,378,000120,473
+100.0%
1.28%
SDGR BuySCHRODINGER INC$3,954,000
+67.5%
115,891
+71.0%
1.16%
+122.1%
KROS BuyKEROS THERAPEUTICS INC$3,953,000
-3.3%
72,690
+4.0%
1.16%
+28.3%
HBIO BuyHARVARD BIOSCIENCE INC$3,936,000
+4.0%
633,826
+18.0%
1.15%
+38.0%
FULC SellFULCRUM THERAPEUTICS INC$3,889,000
-12.1%
164,453
-34.2%
1.14%
+16.6%
OM BuyOUTSET MED INC$3,705,000
+69.9%
81,601
+72.5%
1.08%
+125.4%
SUPN BuySUPERNUS PHARMACEUTICALS INC$3,521,000
+15.3%
108,954
+4.0%
1.03%
+52.8%
PODD SellINSULET CORP$3,375,000
-25.4%
12,671
-25.5%
0.99%
-1.0%
MASS New908 DEVICES INC$3,327,000175,000
+100.0%
0.97%
ANIP SellANI PHARMACEUTICALS INC$3,033,000
-52.0%
107,911
-21.4%
0.89%
-36.3%
PFMT BuyPERFORMANT FINL CORP$2,977,000
+45.3%
957,083
+12.6%
0.87%
+92.7%
CRL SellCHARLES RIV LABS INTL INC$2,840,000
-70.9%
10,000
-61.4%
0.83%
-61.4%
MRVI SellMARAVAI LIFESCIENCES HLDGS I$2,730,000
-34.0%
77,389
-21.6%
0.80%
-12.4%
BuyIMAGO BIOSCIENCES INC$2,693,000
+3.3%
139,751
+27.0%
0.79%
+37.0%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$2,514,000
-36.3%
57,295
-11.6%
0.74%
-15.4%
MNKD BuyMANNKIND CORP$2,485,000
+113.9%
675,403
+154.0%
0.73%
+184.0%
HCAT BuyHEALTH CATALYST INC$2,084,000
-0.1%
79,746
+51.4%
0.61%
+32.3%
MDGL SellMADRIGAL PHARMACEUTICALS INC$1,985,000
-18.3%
20,230
-29.4%
0.58%
+8.4%
KRMD BuyREPRO MED SYS INC$1,923,000
+7.3%
672,457
+12.5%
0.56%
+42.2%
ALT BuyALTIMMUNE INC$1,885,000
-21.9%
309,586
+17.5%
0.55%
+3.8%
GOSS SellGOSSAMER BIO INC$1,738,000
-71.9%
200,185
-63.4%
0.51%
-62.7%
VCYT SellVERACYTE INC$1,672,000
-34.8%
60,651
-2.6%
0.49%
-13.6%
ATRC NewATRICURE INC$1,657,00025,236
+100.0%
0.48%
AKYA BuyAKOYA BIOSCIENCES INC$1,652,000
-13.7%
150,321
+20.3%
0.48%
+14.5%
TKNO BuyALPHA TEKNOVA INC$1,650,000
-23.4%
119,468
+13.6%
0.48%
+1.5%
STRO SellSUTRO BIOPHARMA INC$1,643,000
-50.1%
199,846
-9.7%
0.48%
-33.7%
PSTV NewPLUS THERAPEUTICS INC$1,526,0001,526,316
+100.0%
0.45%
LNTH NewLANTHEUS HLDGS INC$1,399,00025,295
+100.0%
0.41%
LNDC NewLANDEC CORP$1,335,000115,316
+100.0%
0.39%
CNCE NewCONCERT PHARMACEUTICALS INC$1,272,000377,399
+100.0%
0.37%
TELA BuyTELA BIO INC$1,262,000
-5.5%
108,504
+4.0%
0.37%
+25.1%
MRTX BuyMIRATI THERAPEUTICS INC$1,253,000
-33.8%
15,236
+18.0%
0.37%
-12.2%
REPH BuySOCIETAL CDMO INC$1,209,000
+9.5%
671,817
+4.0%
0.35%
+45.1%
SIEN BuySIENTRA INC$1,181,000
-34.6%
531,860
+8.2%
0.35%
-13.1%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$1,175,000
-12.2%
118,247
+4.1%
0.34%
+16.6%
FMTX BuyFORMA THERAPEUTICS HLDGS INC$1,156,000
-18.7%
124,310
+24.3%
0.34%
+7.6%
CTIC NewCTI BIOPHARMA CORP$1,051,000225,000
+100.0%
0.31%
AXGN SellAXOGEN INC$1,024,000
-47.1%
128,947
-37.6%
0.30%
-29.7%
ANAB BuyANAPTYSBIO INC$922,000
-25.9%
37,285
+4.1%
0.27%
-1.8%
PHAT SellPHATHOM PHARMACEUTICALS INC$892,000
-41.5%
65,553
-15.4%
0.26%
-22.3%
ALLK NewALLAKOS INC$867,000152,066
+100.0%
0.25%
ZYME BuyZYMEWORKS INC$781,000
+14.5%
119,286
+186.6%
0.23%
+52.7%
OPNT BuyOPIANT PHARMACEUTICALS INC$697,000
-33.7%
32,557
+4.0%
0.20%
-12.1%
MIRM NewMIRUM PHARMACEUTICALS INC$668,00030,354
+100.0%
0.20%
SURF SellSURFACE ONCOLOGY INC$615,000
-50.3%
209,148
-19.2%
0.18%
-34.1%
BLRX SellBIOLINERX LTDsponsored ads$463,000
-47.0%
270,665
-36.9%
0.14%
-29.5%
EIGR NewEIGER BIOPHARMACEUTICALS INC$415,00050,000
+100.0%
0.12%
RCKT NewROCKET PHARMACEUTICALS INC$401,00025,295
+100.0%
0.12%
MTEM SellMOLECULAR TEMPLATES INC$358,000
-38.2%
103,709
-29.8%
0.10%
-18.0%
NRIX SellNURIX THERAPEUTICS INC$289,000
-88.6%
20,663
-76.5%
0.08%
-84.8%
VSTM BuyVERASTEM INC$269,000
-28.5%
190,755
+4.0%
0.08%
-4.8%
VERA ExitVERA THERAPEUTICS INCcl a$0-21,555
-100.0%
-0.13%
ONCT ExitONCTERNAL THERAPEUTICS INC$0-289,280
-100.0%
-0.14%
ICAD ExitICAD INC$0-103,302
-100.0%
-0.16%
QTRX ExitQUANTERIX CORP$0-20,000
-100.0%
-0.19%
CSLT ExitCASTLIGHT HEALTH INCcl b$0-625,678
-100.0%
-0.21%
ExitRAPID MICRO BIOSYSTEMS INC$0-100,000
-100.0%
-0.24%
HALO ExitHALOZYME THERAPEUTICS INC$0-41,333
-100.0%
-0.37%
SMLR ExitSEMLER SCIENTIFIC INC$0-21,419
-100.0%
-0.43%
ETNB Exit89BIO INC$0-152,098
-100.0%
-0.44%
ANGO ExitANGIODYNAMICS INC$0-87,969
-100.0%
-0.54%
IONS ExitIONIS PHARMACEUTICALS INC$0-80,238
-100.0%
-0.54%
STXS ExitSTEREOTAXIS INC$0-413,218
-100.0%
-0.56%
RGEN ExitREPLIGEN CORP$0-10,331
-100.0%
-0.60%
KOD ExitKODIAK SCIENCES INC$0-35,174
-100.0%
-0.66%
BRKS ExitAZENTA INC$0-36,554
-100.0%
-0.83%
XRAY ExitDENTSPLY SIRONA INC$0-73,566
-100.0%
-0.91%
HZNP ExitHORIZON THERAPEUTICS PUB L$0-100,747
-100.0%
-2.40%
XBI ExitSPDR SER TRcall$0-100,000
-100.0%
-2.47%
HCA ExitHCA HEALTHCARE INC$0-50,661
-100.0%
-2.87%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC16Q3 20236.3%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
XENON PHARMACEUTICALS INC16Q3 20233.3%
NATERA INC16Q3 20233.4%
AVID BIOSERVICES INC15Q3 20232.9%
SCHRODINGER INC15Q3 20234.2%
REPRO MED SYS INC15Q2 20232.0%
MANNKIND CORP15Q3 20231.6%
IQVIA HLDGS INC14Q1 20234.6%
INSULET CORP14Q3 20232.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings